LOX and hepatocellular carcinoma: Another study presents an innovative approach utilizing a platelet membrane-engineered nanoparticle loaded with erastin, superparamagnetic iron oxide (SPIO) nanoparticles, and LOX to enhance HCC treatment through ferroptosis and immunotherapy.